Atomfair

Awaiting product image

Atomfair Ginsenoside Rg5 C42H70O12

Description Ginsenoside Rg5 (CAS 143613-17-6) is a high-purity, bioactive saponin derived from Panax ginseng , extensively studied for its pharmacological properties. With the molecular formula C42H70O12, this ginsenoside exhibits a complex tetracyclic triterpenoid structure, characterized by a dammarane-type skeleton with sugar moieties. Our product is rigorously tested via HPLC (>98% purity) and NMR to ensure structural integrity, making it ideal for research in nutraceuticals, oncology, and neuroprotection. Supplied as a white to off-white powder, it is soluble in DMSO and ethanol, with strict storage recommendations at -20??C to maintain stability. Each batch includes comprehensive analytical documentation (CoA, MSDS) for regulatory…

Category:
Brands:

Description

Description

Ginsenoside Rg5 (CAS 143613-17-6) is a high-purity, bioactive saponin derived from Panax ginseng, extensively studied for its pharmacological properties. With the molecular formula C42H70O12, this ginsenoside exhibits a complex tetracyclic triterpenoid structure, characterized by a dammarane-type skeleton with sugar moieties. Our product is rigorously tested via HPLC (>98% purity) and NMR to ensure structural integrity, making it ideal for research in nutraceuticals, oncology, and neuroprotection. Supplied as a white to off-white powder, it is soluble in DMSO and ethanol, with strict storage recommendations at -20??C to maintain stability. Each batch includes comprehensive analytical documentation (CoA, MSDS) for regulatory compliance and reproducibility.

  • CAS No: 143613-17-6
  • Molecular Formula: C42H70O12
  • Molecular Weight: 767.0
  • Exact Mass: 766.48672766
  • Monoisotopic Mass: 766.48672766
  • IUPAC Name: (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2E)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
  • SMILES: CC(=CC/C=C(C)/[C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)C
  • Synonyms: Ginsenoside Rg5, 186763-78-0, Ginsenoside-Rg5, (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2E)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol, DTXSID501317132

Application

Ginsenoside Rg5 is a promising candidate for cancer research due to its reported anti-proliferative effects via modulation of apoptosis pathways (e.g., caspase-3 activation). Studies suggest neuroprotective potential by inhibiting oxidative stress and amyloid-beta aggregation in Alzheimer’s models. It also demonstrates anti-inflammatory activity through NF-??B suppression, making it relevant for metabolic disorder investigations. Researchers utilize Rg5 in pharmacokinetic studies to explore its bioavailability and metabolite profiling.

If you are interested or have any questions, please contact us at support@atomfair.com